Heart failure & cardiomyopathies

Detection of Hypertrophic Cardiomyopathy on Electrocardiogram Using Artificial Intelligence

Circ Heart FailPublished diagnostic accuracy study of an artificial intelligence device

Authors' conclusion

The device identified HCM based on a 12-lead electrocardiogram with good performance. Coupled with clinical expertise, it has the potential to augment HCM detection and diagnosis.

Study context

Population
Hypertrophic cardiomyopathy (HCM)-positive and HCM-negative cases with 12-lead electrocardiograms, selected based on chart review incorporating billing diagnostic codes, cardiac imaging, and electrocardiogram features293 HCM-positive and 2912 HCM-negative cases, device output for 291 (99.3%) HCM-positive and 2905 (99.8%) HCM-negative cases · HCM-positive 293 · HCM-negative 2,912
Index test or model
Viz HCM vs chart review incorporating billing diagnostic codes, cardiac imaging, and electrocardiogram features
Target condition
Hypertrophic cardiomyopathy (HCM)
Methodological details3 hospitals
  • 3 hospitals

Performance

As reported in the abstract

Sensitivity

68.4%

95% CI 62.8–73.5%

Specificity

99.1%

95% CI 98.7–99.4%

Area under the curve

0.975

95% CI 0.965–0.982

Further findings

Predictive values at assumed population prevalence of 0.002 (1 in 500)

Positive predictive value
13.7% (95% CI, 10.1-19.9%)
Negative predictive value
99.9% (95% CI, 99.9-99.9%)

Performance across demographic and technical subgroups

Broadly consistent performance across demographic and technical subgroups

Original publication

Detection of Hypertrophic Cardiomyopathy on Electrocardiogram Using Artificial Intelligence. Circ Heart Fail. Published 14 May 2025. doi:10.1161/circheartfailure.124.012667

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.